RUFFOLO ROBERT R — SEC insider filings

SEC reporting owner CIK 1187308. 14 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2020-12-07 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sigilon Therapeutics, Inc. (SGTX)Director6—1 leg · 6,750 sh · $69,9309
LB PHARMACEUTICALS INC (LBRX)Director2——8
Elicio Therapeutics, Inc. (ELTX)Director4——4
Aridis Pharmaceuticals, Inc. (ARDS)Director2——2

Insider filings — RUFFOLO ROBERT R

FiledFormIssuerReported transactionsSource
2026-09-024Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 21,750 (derivative) @ $0EDGAR
2026-06-054LB PHARMACEUTICALS INC (LBRX)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-09-124LB PHARMACEUTICALS INC (LBRX)Disposition to issuer (D): 1,792 (derivative) · Grant/award (A): 1,792 (derivative) · Disposition to issuer (D): 717 (derivative) · Grant/award (A): 717 (derivative) · Disposition to issuer (D): 10,757 (derivative) · Grant/award (A): 10,757 (derivative) · +1 moreEDGAR
2025-05-204Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 7,900 (derivative) @ $0EDGAR
2024-11-254Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 4,100 (derivative) @ $0EDGAR
2023-12-294Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 4,100 (derivative) @ $0EDGAR
2023-08-114Sigilon Therapeutics, Inc. (SGTX)Disposition to issuer (D): 683 (derivative) @ $6.64 · Disposition to issuer (D): 683 (derivative) @ $5.00 · Disposition to issuer (D): 3,754 (derivative) @ $7.51EDGAR
2023-05-224Sigilon Therapeutics, Inc. (SGTX)Grant/award (A): 8,888 (derivative) @ $0EDGAR
2022-12-074Aridis Pharmaceuticals, Inc. (ARDS)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-05-274Sigilon Therapeutics, Inc. (SGTX)Grant/award (A): 8,888 (derivative) @ $0EDGAR
2021-10-054Aridis Pharmaceuticals, Inc. (ARDS)Grant/award (A): 7,000 (derivative) @ $0EDGAR
2021-07-024Sigilon Therapeutics, Inc. (SGTX)Option exercise (M): 6,750 @ $0.57 · Sale (S): 6,750 @ $10.36 · Option exercise (M): 6,750 (derivative) @ $0EDGAR
2021-06-284Sigilon Therapeutics, Inc. (SGTX)Grant/award (A): 8,888 (derivative) @ $9.97EDGAR
2020-12-074Sigilon Therapeutics, Inc. (SGTX)Grant/award (A): 8,888 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1187308 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs